Purple Biotech Ltd reported break-even for the forth quarter of 2022 compare to earnings per share of $0.00 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.
forth quarter of 2022
Earnings Per Share
Revenues
$ 0
$
0 Mill
Unch.
Unch.
Purple Biotech Ltd 's Revenue
fell by
0 % in forth quarter of 2022 (Dec 31 2022) year on year,
to $0 million and
declined by
sequentially.
Purple Biotech Ltd is Expected to report next financial results on March 02, 2024.
Purple Biotech Ltd 's
net income of $21.760 million in the forth quarter of 2022 increased by 17.83 % from net earnings of $18.468 million achieved in IV. Quarter a year ago.
Sequentially
Company turn into Profitability from net loss of $0.000 million recorded in previous quarter.
Purple Biotech Ltd Inventories PPBT's Cash flow
In theforth quarter of 2022 company's net cash flow was $11 million, capital expenditures grew by -77.39%, to $0 millions compare to same quarter a year ago and fell by
